Comparison of the Efficacy of Dry Needling, Ischemic Compression, and Cross Taping on Masseter Myofascial Pain: A Randomized Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Pain intensity
研究概览
简要总结
The goal of this clinical trial is to learn whether Dry Needling, Ischemic Compression, and Cross Tapes work to treat myofascial pain in masseter muscles in adults. It will also learn about the safety of this treatment. The main questions it aims to answer are:
- Do Dry Needling, Ischemic Compression, and Cross Tapes relieve masseter muscle pain?
- Which of these treatments provides the best relief from masseter muscle pain? Researchers will compare these three treatments to see which is best for treating masseter muscle pain.
Participants will:
Treated with Dry Needling or Ischemic Compression or Cross Tapes only once Visit the clinic one week, three months, and six months after treatment.
详细描述
The taut band represents the most commonly observed muscular disorder, where myofascial trigger points may arise, causing referred pain in another location. Therapeutic strategies applied for its treatment include dry needling, ischemic compression, and cross-taping.
Objectives: To compare the effectiveness of these treatment methods in reducing or alleviating the intensity of pain in the masseter.
In this multicenter randomized clinical trial, the study sample underwent a clinical examination according to the Diagnostic Criteria for Temporomandibular Disorders to diagnose the presence of orofacial myofascial pain with taut bands in the masseter. Participants were randomly allocated to three groups based on the treatment methods.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients with myofascial pain diagnosed according Diagnostic Criteria for Temporomandibular Disorders (DC-TMD).
排除标准
- •Pregnant women
- •Other TMD-spectrum pathologies
- •Anticoagulated and antiaggregated individuals
- •Blood disorders
- •Fibromyalgia
- •Autoimmune diseases in acute stages
- •Neurological diseases
- •Malignant tumor pathologies
- •Patients with aichthyophobia
- •Concomitant medication (opioids, antidepressants, myorelaxants)
研究组 & 干预措施
Group 1
干预措施: Dry Needling (Procedure)
Group 2
干预措施: Ischemic Compression (Procedure)
Group 3
干预措施: Cross Tapes (Procedure)
结局指标
主要结局
Pain intensity
时间窗: At baseline, immediately after the intervention, 1 week, and 1 month after treatment
Pain intensity will be assessed using the Numerical Pain Rating Scale, where 0 represents the absence of pain, and 10 describes the worst possible pain.
次要结局
未报告次要终点
研究者
Bruno Macedo de Sousa
Professor
University of Coimbra